These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10939192

  • 1. [Usefulness of the relationship between follicular stimulating hormone, deoxypyridinoline, estradiol, and inhibin as decision criterion for starting replacement hormone therapy in climacteric and its correlation with symptomatology].
    Carranza Lira S, Cortés Fuentes E, González Legorreta SL.
    Ginecol Obstet Mex; 2000 Jun; 68():242-8. PubMed ID: 10939192
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women.
    Santoro N, Lo Y, Moskaleva G, Arnsten JH, Floris-Moore M, Howard AA, Adel G, Zeitlian G, Schoenbaum EE.
    Menopause; 2007 Jun; 14(5):859-65. PubMed ID: 17415019
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women.
    Guthrie JR, Dennerstein L, Hopper JL, Burger HG.
    Obstet Gynecol; 1996 Sep; 88(3):437-42. PubMed ID: 8752255
    [Abstract] [Full Text] [Related]

  • 6. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
    Lai A, Zhang J, Ding L.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
    [Abstract] [Full Text] [Related]

  • 7. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P.
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women.
    De Pergola G, Maldera S, Tartagni M, Pannacciulli N, Loverro G, Giorgino R.
    Obesity (Silver Spring); 2006 Nov; 14(11):1954-60. PubMed ID: 17135611
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Correlation of Kupperman's index with estrogen and androgen levels, according to weight and body fat distribution in postmenopausal women from Mexico City.
    Carranza-Lira S, Velasco Díaz G, Olivares A, Chán Verdugo R, Herrera J.
    Int J Fertil Womens Med; 2006 Nov; 51(2):83-8. PubMed ID: 16881384
    [Abstract] [Full Text] [Related]

  • 12. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone.
    Perrien DS, Achenbach SJ, Bledsoe SE, Walser B, Suva LJ, Khosla S, Gaddy D.
    J Clin Endocrinol Metab; 2006 May; 91(5):1848-54. PubMed ID: 16449331
    [Abstract] [Full Text] [Related]

  • 13. [Study on serum inhibin concentrations in women during menopausal transition].
    Zhang YW, Chen WL, Yu Q, Song YH, Zhou J, Zhang DY.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):98-101. PubMed ID: 12783698
    [Abstract] [Full Text] [Related]

  • 14. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y, Yu Q, Zhang YW, He FF, Sun ZY.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [Abstract] [Full Text] [Related]

  • 15. [The evaluation of estradiol and FSH serum levels in menopausal women with primary cataract].
    Dolatowska E.
    Klin Oczna; 2002 Jun; 104(5-6):357-61. PubMed ID: 12664480
    [Abstract] [Full Text] [Related]

  • 16. Inhibin A and B as markers of menopause: a five-year prospective longitudinal study of hormonal changes during the menopausal transition.
    Overlie I, Mørkrid L, Andersson AM, Skakkebaek NE, Moen MH, Holte A.
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):281-5. PubMed ID: 15715537
    [Abstract] [Full Text] [Related]

  • 17. Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.
    Kawai H, Furuhashi M, Suganuma N.
    Arch Gynecol Obstet; 2004 Mar; 269(3):192-5. PubMed ID: 13680264
    [Abstract] [Full Text] [Related]

  • 18. Serum estradiol and follicle-stimulating hormone levels in Thai women post total abdominal hysterectomy and bilateral oophorectomy using oral 17 beta-estradiol.
    Bunyavejchevin S, Panthong C, Limpaphayom KK.
    J Med Assoc Thai; 2002 Jan; 85(1):58-62. PubMed ID: 12075721
    [Abstract] [Full Text] [Related]

  • 19. SUMEVA, a new system of climacteric symptom evaluation, and its correlation with FSH and estradiol levels.
    Carranza-Lira S, Reyes Razo BP, Chán Verdugo R.
    Int J Fertil Womens Med; 2006 Jan; 51(3):140-4. PubMed ID: 17039859
    [Abstract] [Full Text] [Related]

  • 20. Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women?
    Hansen KR, Thyer AC, Sluss PM, Bremner WJ, Soules MR, Klein NA.
    Hum Reprod; 2005 Jan; 20(1):89-95. PubMed ID: 15550499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.